XML 19 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating Costs and Expenses:    
General and administrative $ 7,396 $ 7,120
Research and development 12,031 14,311
In-process research and development impairment 1,325 0
Goodwill impairment 5,594 0
Total Operating Costs and Expenses 26,346 21,431
Loss from Operations (26,346) (21,431)
Other Income:    
Foreign currency exchange (loss) gain (4) 3
Interest income 697 1,439
Total Other Income 693 1,442
Net Loss before income taxes (25,653) (19,989)
Income tax benefit 0 1,640
Net Loss Attributable to Common Stockholders $ (25,653) $ (18,349)
Net Loss Per Share - Basic (in dollars per share) $ (19.03) $ (28.48)
Net Loss Per Share - Dilutive (in dollars per share) $ (19.03) $ (28.48)
Weighted average number of shares outstanding during the period - Basic (in shares) 1,348,126 644,282
Weighted average number of shares outstanding during the period - dilutive (in shares) 1,348,126 644,282
Net Loss $ (25,653) $ (18,349)
(Loss) gain (loss) on foreign currency translation (1,210) 711
Total comprehensive loss $ (26,863) $ (17,638)